|
PDSB PDS Biotechnology Corp 1472091 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-9,750,575.00 |
| Balance Sheet |
|
Current Assets
|
$7,045,193.00 |
|
Assets
|
$8,807,213.00 |
|
Current Liabilities
|
$12,377,476.00 |
|
Liabilities
|
$12,386,952.00 |
|
Equity
|
$-3,579,739.00 |
|
Shares Out
|
55921806.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-7,164,155.00 |
| Market Analysis |
Market Cap
|
$11,743,579.26 |
|
Price
|
$0.21 |
|
BVPS
|
0.07 |
|
PB
|
3.00 |
|
EPS
|
-0.18 |
|
FCF
|
$-7,164,155.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:54 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:45 |
|
| Apr |
May |
Jun |
| 2026-03-30 |
-0.74 |
|
|
2026-05-13 |
-0.13 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-13 |
-0.21 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-13 |
-0.19 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view PDSB documents filed with the SEC.
PDSB Filings
Clear
